Tdap Titer Panel
This Tdap titer blood test panel checks antibody levels for tetanus, diphtheria, and pertussis to help you confirm vaccine protection.
This panel bundles multiple biomarker tests in one order—your report explains how results fit together.
This is not a single lab value. The Tdap Titer Panel is a bundled blood test that looks at multiple antibodies related to the Tdap vaccine (tetanus, diphtheria, and pertussis). Your results are most useful when you read them together: they can show whether you have measurable protection, whether immunity looks uneven across components, and whether follow-up (like a booster or repeat testing) is worth discussing.
Do I need this panel?
You may consider the Tdap Titer Panel if you want objective confirmation of your immune response to vaccination—especially when you cannot easily verify your vaccine records, you are starting a new job or training program with immunization requirements, or you are trying to reduce uncertainty before travel or caregiving.
This panel can also be helpful if you were vaccinated years ago and you are wondering whether your protection has likely waned. While Tdap boosters are commonly recommended on a schedule, antibody testing can add context when timing is unclear, when you have a history of missed doses, or when you want documentation of immunity for a specific requirement.
If you have a condition or medication that may blunt immune responses (for example, certain immunosuppressive therapies), a titer panel can help you and your clinician understand whether you mounted antibodies after vaccination and whether additional steps are needed.
Your results should support clinician-directed decisions rather than self-diagnosis. Immunity is nuanced, and vaccine guidance depends on your age, pregnancy status, exposure risk, and medical history.
This panel measures vaccine-related antibodies in blood; methods and protective thresholds can vary by lab, so interpretation should follow the reference ranges and notes on your report.
Lab testing
Order the Tdap Titer Panel
Schedule online, results typically within about a week
Clear reporting and optional clinician context
HSA/FSA eligible where applicable
Get this panel with Vitals Vault
Vitals Vault makes it straightforward to order a lab panel when you want clarity without turning your results into a confusing spreadsheet. You can use the Tdap Titer Panel to check multiple immunity markers from one blood draw and then organize next steps based on the pattern across the panel.
After you receive results, PocketMD can help you translate them into practical questions: Which components show strong antibodies? Which are borderline? Do your results fit with your vaccine history and risk level? If you need documentation for work or school, you can also keep your report accessible for future reference.
If your goals broaden beyond vaccine immunity—like building a baseline for cardiometabolic health or performance—you can use your results as a starting point and add a more comprehensive panel when it makes sense.
- One order, one draw: multiple vaccine-related antibody results in a single panel
- Clear next-step planning with PocketMD for follow-up questions and retest timing
- Designed for preventive planning and documentation, not just reactive testing
Key benefits of the Tdap Titer Panel
- Checks multiple antibodies in one panel so you can assess tetanus, diphtheria, and pertussis immunity together.
- Helps you document immune status when vaccine records are missing, incomplete, or hard to access.
- Highlights uneven protection (for example, strong tetanus antibodies but weaker pertussis markers) that a single test could miss.
- Supports risk-based decisions about boosters, especially when timing since your last dose is uncertain.
- Adds context for people with possible reduced vaccine response due to medical conditions or immune-modifying medications.
- Reduces “panel overload” by focusing on a specific question—Tdap-related protection—rather than a broad, unfocused lab bundle.
- Creates a baseline you can compare against future results if you retest after vaccination or a change in health status.
What is the Tdap Titer Panel?
The Tdap Titer Panel is a lab panel that measures antibodies in your blood related to the three diseases covered by the Tdap vaccine: tetanus, diphtheria, and pertussis (whooping cough). A “titer” is a way of describing the amount of antibody detected—your immune system’s measurable response to prior vaccination or exposure.
This panel is different from a general “immunity” screen because it is targeted. It focuses on antibodies that are commonly used to assess protection or immune response to these vaccine antigens. The exact test names and thresholds can vary by laboratory, but the goal is the same: to give you a multi-part snapshot of Tdap-related immunity.
Antibodies are only one part of immune protection. Your immune system also relies on immune memory (including T-cell responses), which is not fully captured by routine titer testing. That is why your results are best interpreted as supportive evidence—useful for documentation and planning—rather than a perfect yes/no answer about whether you can or cannot get sick.
Because this is a panel, you should read it as a pattern. For example, tetanus and diphtheria antibody tests often reflect longer-lasting responses, while pertussis immunity can be more complex and may wane over time even after vaccination. Your personal risk (work exposure, household contacts, pregnancy, travel, outbreaks) matters when deciding what to do with the numbers.
What do my panel results mean?
Low or non-protective pattern across the panel
If multiple components of the panel are low (for example, low tetanus and diphtheria antibodies, with low or negative pertussis markers), it can suggest limited measurable antibody protection or a waning response. This pattern is more likely if it has been many years since your last booster, if your vaccine series was incomplete, or if your immune system did not mount a strong response. In practice, low results often lead to a conversation about updating vaccination and, in some cases, retesting after vaccination if documentation of response is important for your situation.
Reassuring pattern (antibodies detected where expected)
A reassuring panel usually shows measurable antibodies to tetanus and diphtheria, with pertussis markers that align with your vaccine timing and the lab’s interpretation notes. This pattern supports that you have an immune response consistent with prior vaccination. Even with “good” titers, the right next step depends on your risk level and local guidance—some people still need boosters on a schedule (or during pregnancy) regardless of titers, while others mainly need documentation that immunity is present.
High pattern (strong antibody signals)
Higher antibody levels across one or more components often reflect a recent booster, recent vaccination series completion, or a strong immune response. High results are not usually a problem by themselves; they typically mean your immune system recognizes these antigens well. If pertussis-related markers are especially high, interpretation can be more nuanced because different pertussis assays measure different antibody targets, and levels can be influenced by recent vaccination versus recent exposure—your report’s comments and your clinical context matter.
Factors that influence Tdap titer results
Timing is a major driver: antibody levels generally rise after vaccination and can decline over time, and different components may wane at different rates. Lab methodology also matters—different assays, targets, and cutoffs can change whether a result is labeled “immune,” “equivocal,” or “non-immune.” Your age, pregnancy status, and immune function can affect antibody production, as can immune-modifying medications (such as certain biologics, steroids, or chemotherapy). Finally, documentation needs vary: a school or employer may require specific tests or thresholds, so it helps to confirm what is accepted before you rely on a particular panel for clearance.
What’s included in this panel
- Bordetella Pertussis Toxin(Pt) Ab (Igg), Ia
- Diphtheria Antitoxoid
- Tetanus Antitoxoid
Frequently Asked Questions
Do I need to fast for the Tdap Titer Panel?
Fasting is usually not required for antibody (titer) testing. If you are combining this panel with other labs that do require fasting, follow the instructions for the full set of tests you are ordering.
Can this panel tell me if I’m “immune” to tetanus, diphtheria, and pertussis?
It can show whether antibodies are detected and whether they meet the lab’s criteria for protective or expected levels, but immunity is not a single on/off switch. Protection also depends on immune memory and your exposure risk. Use the panel as documentation and decision support, not as a guarantee.
Why do pertussis results sometimes look different from tetanus and diphtheria?
Pertussis antibody testing is more variable across labs and can be influenced by which antibody targets are measured and how results are categorized. Pertussis immunity can also wane over time, and antibody patterns may reflect recent vaccination versus possible exposure. Your report’s interpretive notes are especially important for pertussis.
Is it better to order these tests separately or as a panel?
A panel is often simpler because it bundles the key Tdap-related markers into one order and makes it easier to interpret the pattern across components. Ordering separately can make sense if you only need documentation for one disease component or if a specific institution requires a particular assay.
How often should I repeat a Tdap titer panel?
Repeat timing depends on why you tested. If you are documenting response after vaccination, retesting is often done after enough time has passed for antibodies to rise (your clinician or the ordering guidance can help with timing). If you are using titers for periodic documentation, the interval depends on workplace or school requirements and your booster schedule.
What if my results are low—does that mean I should get a booster right away?
Low titers can be a reason to discuss vaccination timing, but the right next step depends on your vaccine history, age, pregnancy status, and exposure risk. Some people should follow standard booster recommendations regardless of titers, while others may use titers to guide documentation or follow-up. If you are immunocompromised, decisions may be more individualized.
Can medications or health conditions affect my titer results?
Yes. Immune-modifying medications and certain health conditions can reduce antibody production or change how long antibodies stay detectable. If you are on immunosuppressive therapy or have a condition affecting immune function, share that context when interpreting results.